4//SEC Filing
Holmes Scott A 4
Accession 0001114220-18-000035
CIK 0001114220other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:31 PM ET
Size
10.3 KB
Accession
0001114220-18-000035
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Award
Common Stock
2018-03-20+41,250→ 172,469 total - Award
Stock Options (right to buy)
2018-03-20+82,500→ 82,500 totalExercise: $4.16From: 2019-03-20Exp: 2028-03-20→ Common Stock (82,500 underlying)
Footnotes (3)
- [F1]The 41,250 shares are restricted common stock, with one-third of the 41,250 shares vesting on March 20, 2019 and one-twelfth vesting on each of June 20, 2019, September 20, 2019, December 20, 2019, March 20, 2020, June 20, 2020, September 20, 2020, December 20, 2020 and March 20, 2021.
- [F2]Includes 99,163 shares of restricted stock.
- [F3]The stock options vest according to the following schedule: one-third of the 82,500 options will vest on March 20, 2019 and one-twelfth will vest on each of June 20, 2019, September 20, 2019, December 20, 2019, March 20, 2020, June 20, 2020, September 20, 2020, December 20, 2020 and March 20, 2021.
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeother
Related Parties
1- filerCIK 0001537670
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 5:31 PM ET
- Size
- 10.3 KB